Redefining PRRT: Advancing EBTATE Towards a New Standard of Care for Gastroenteropancreatic Neuroendocrine Tumours

Name: Redefining PRRT: Advancing EBTATE Towards a New Standard of Care for Gastroenteropancreatic Neuroendocrine Tumours
Start: 2026-12-03T09:30
Location: Renaissance London Heathrow Hotel

Targeted Radiopharmaceuticals Summit EU 2026 · 3 December 2026 · 09:30

Redefining PRRT: Advancing EBTATE Towards a New Standard of Care for Gastroenteropancreatic Neuroendocrine Tumours was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 3 December 2026 in London, with 1 speaker on record.

Speakers

Chris Pak — Speaker President & Chief Executive Officer, Molecular Targeting Technologies